Royalty Pharma plc is the largest buyer of biopharmaceutical royalties, founded in 1996. It acquires royalties entitling it to payments based on top-line sales of leading therapies including Vertex's Trikafta, GSK's Trelegy, Biogen's Tysabri and Spinraza, Roche's Evrysdi, Xtandi, Tremfya, Imbruvica, Trodelvy, Amvuttra, and others. As of December 31, 2025, its portfolio includes royalties on more than 35 marketed products and 20 development-stage candidates, generating $3.3 billion in Portfolio Receipts in 2025.
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-11 | 2025-12-31 | 0001802768-26-000003 | EDGAR | 77K words |
| 2025-02-12 | 2024-12-31 | 0001802768-25-000010 | EDGAR | 76K words |
| 2024-02-15 | 2023-12-31 | 0001802768-24-000012 | EDGAR | 74K words |
| 2023-02-15 | 2022-12-31 | 0001802768-23-000007 | EDGAR | 93K words |
| 2022-02-15 | 2021-12-31 | 0001802768-22-000011 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001802768-21-000006 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001802768-26-000015 | EDGAR | 55K words |
| 2025-11-05 | 2025-09-30 | 0001802768-25-000114 | EDGAR | 59K words |
| 2025-08-06 | 2025-06-30 | 0001802768-25-000095 | EDGAR | 58K words |
| 2025-05-08 | 2025-03-31 | 0001802768-25-000027 | EDGAR | 51K words |
| 2024-11-06 | 2024-09-30 | 0001802768-24-000058 | EDGAR | 53K words |
| 2024-08-08 | 2024-06-30 | 0001802768-24-000045 | EDGAR | 53K words |
| 2024-05-09 | 2024-03-31 | 0001802768-24-000021 | EDGAR | 48K words |
| 2023-11-08 | 2023-09-30 | 0001802768-23-000029 | EDGAR | 65K words |
| 2023-08-08 | 2023-06-30 | 0001802768-23-000023 | EDGAR | 64K words |
| 2023-05-09 | 2023-03-31 | 0001802768-23-000015 | EDGAR | 59K words |
| 2022-11-08 | 2022-09-30 | 0001802768-22-000045 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001802768-22-000035 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001802768-26-000014 | EDGAR | 6K words |
| 2026-02-11 | 0001802768-26-000002 | EDGAR | 7K words |
| 2025-12-22 | 0001193125-25-328759 | EDGAR | 1K words |
| 2025-12-22 | 0001193125-25-328100 | EDGAR | 1K words |
| 2025-11-05 | 0001802768-25-000113 | EDGAR | 6K words |
| 2025-09-16 | 0001193125-25-204983 | EDGAR | 23K words |
| 2025-08-13 | 0001193125-25-179892 | EDGAR | 0K words |
| 2025-08-06 | 0001193125-25-173988 | EDGAR | 8K words |
| 2025-07-17 | 0001193125-25-160293 | EDGAR | 1K words |
| 2025-05-19 | 0000950103-25-006186 | EDGAR | 47K words |
112 total filings indexed. 84 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001802768 |
| Ticker | RPRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | X0 |
| Website | https://www.royaltypharma.com |
| Listed | 2020-06-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RPRX (~200 tokens, structured JSON with cryptographic provenance)